Senores Pharmaceuticals Ltd
SENORES price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- SENORES
- MB Code
- MBEQU4381
- ISIN
- INE0RB801010
- BSE code
- 544319
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 175.19 Cr
- Net profit
- 36.67 Cr
- EPS
- 7.96
- YoY revenue
- +53.39%
Company documents
10 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for SENORES
EPS 7.96 vs est. 7.12
Beat estimates by 11.80%
Senores Pharmaceuticals expects to exceed its FY26 growth target, anticipating revenue from emerging markets to reach ₹150 crore this yea…
Senores Pharmaceuticals anticipates significant revenue growth following its acquisition of Apnar Pharma, projecting ₹250 crore by FY28. …
Senores Pharmaceuticals is identified as a strong growth stock for Diwali, focusing on US and Canada markets with USFDA-approved faciliti…
Price returns
Historical performance
Technicals
Indicator consensus